Low IGF-I Concentrations Research Articles

The High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Polymorphisms Are Differentially Associated With Growth and IGF-I Levels in Infancy: The Cambridge Baby Growth Study.

This study explored the link between HLA polymorphisms that predispose to type 1 diabetes and birth size, infancy growth, and/or circulating IGF-I in a general population-based birth cohort. The Cambridge Baby Growth Study is a prospective observational birth cohort study that recruited 2,229 newborns for follow-up in infancy. Of these, 612 children had DNA available for genotyping single nucleotide polymorphisms in the HLA region that capture the highest risk of type 1 diabetes: rs17426593 for DR4, rs2187668 for DR3, and rs7454108 for DQ8. Multivariate linear regression models at critical ages (cross-sectional) and mixed-effects models (longitudinal) were performed under additive genetic effects to test for associations between HLA polymorphisms and infancy weight, length, skinfold thickness (indicator of adiposity), and concentrations of IGF-I and IGF-binding protein-3 (IGFBP-3). In longitudinal models, the minor allele of rs2187668 tagging DR3 was associated with faster linear growth (P = 0.007), which was more pronounced in boys (P = 3 × 10-7) than girls (P = 0.07), and was also associated with increasing IGF-I (P = 0.002) and IGFBP-3 (P = 0.003) concentrations in infancy. Cross-sectionally, the minor alleles of rs7454108 tagging DQ8 and rs17426593 tagging DR4 were associated with lower IGF-I concentrations at age 12 months (P = 0.003) and greater skinfold thickness at age 24 months (P = 0.003), respectively. The variable associations of DR4, DR3, and DQ8 alleles with growth measures and IGF-I levels in infants from the general population could explain the heterogeneous growth trajectories observed in genetically at-risk cohorts. These findings could suggest distinct mechanisms involving endocrine pathways related to the HLA-conferred type 1 diabetes risk.

Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature.

Data on sex differences in acromegaly at the time of diagnosis vary considerably between studies. A nationwide cohort study including all incident cases of acromegaly (1978-2010, n=596) and a meta-analysis on sex differences in active acromegaly (40 studies) were performed. Sex-dependent differences in prevalence, age at diagnosis, diagnostic delay, pituitary adenoma size, insulin-like growth factor 1 (IGF-I) and growth hormone (GH) concentrations were estimated. The cohort study identified a balanced gender distribution (49.6% females) and a comparable age (years) at diagnosis (48.2 CI95% 46.5-49.8 (males) vs. 47.2 CI95% 45.5-48.9 (females), p=0.4). The incidence rate significantly increased during the study period (R2 =0.42, p<0.01) and the gender ratio (F/M) changed from female predominance to an even ratio (SR: 1.4 vs. 0.9, p=0.03). IGF-ISDS was significantly lower in females compared to males, whereas neither nadir GH nor pituitary adenoma size differed between males and females. In the meta-analysis, the weighted percentage female was 53.3% (CI95% 51.5-55.2) with considerable heterogeneity (I2 =85%) among the studies. The mean age difference at diagnosis between genders was 3.1years (CI95% 1.9-4.4), and the diagnostic delay was longer in females by 0.9years (CI95% -0.4 to 2.1). Serum IGF-I levels were significantly lower in female patients, whereas nadir GH, and pituitary adenoma size were comparable. There are only a minor sex differences in the epidemiology of acromegaly at the time of diagnosis except that female patients are slightly older and exhibit lower IGF-I concentrations and a longer diagnostic delay.

ALS deficiency caused by an exon 2 deletion and a novel missense variant in the gene encoding ALS

ContextALS deficiency (ACLSD), caused by mutations in IGFALS, is characterized by a mild short stature, low concentrations of IGF-I and IGFBP-3, and a normal growth hormone (GH) stimulation test response. To our knowledge, no larger deletions have been reported. Case descriptionA 17-year-old adolescent male was evaluated due to delayed puberty and short stature. He had a height of 154.4 cm (SDS -2.84), a weight of 53.3 kg (SDS -1.41), a BMI of 22.4 kg/m2 (SDS +0.31), a Tanner 2 pubertal stage with a testicular volume of 10 mL, and a bone age of 16 years (SDS -1.33). After biochemical evaluation, low IGF-I levels, undetectable IGFBP-3 levels, and a normal response to the GH stimulation test were observed, suggesting GH insensitivity. ACLSD was confirmed by ALS measurement (116 ng/mL, SDS -3.19) and genetic analysis of IGFALS. An apparently homozygous missense variant, p. Pro624Leu, was found in exon 2 of the proband; this mutation was observed on one allele of the proband's father but was absent in the mother and siblings. Deletion/duplication analysis by multiplex ligation-dependent probe amplification (MLPA) was consistent with a deletion encompassing a significant part of exon 2 on one allele in the proband and in his mother and siblings. ConclusionThis is the first report of a large deletion in a patient with ACLSD. Deletion/duplication analysis should be considered in the genetic study of ACLSD, especially when homozygosity for a pathogenic variant cannot be confirmed by the study of the parents or when no variants are found but ALS concentrations are very low.

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.

Insulin‐like growth factors (IGFs) and insulin‐like growth factor binding proteins (IGFBPs) have been implicated in the aetiology of several cancers. To better understand whether anthropometric, behavioural and sociodemographic factors may play a role in cancer risk via IGF signalling, we examined the cross‐sectional associations of these exposures with circulating concentrations of IGFs (IGF‐I and IGF‐II) and IGFBPs (IGFBP‐1, IGFBP‐2 and IGFBP‐3). The Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset includes individual participant data from 16,024 male controls (i.e. without prostate cancer) aged 22–89 years from 22 prospective studies. Geometric means of protein concentrations were estimated using analysis of variance, adjusted for relevant covariates. Older age was associated with higher concentrations of IGFBP‐1 and IGFBP‐2 and lower concentrations of IGF‐I, IGF‐II and IGFBP‐3. Higher body mass index was associated with lower concentrations of IGFBP‐1 and IGFBP‐2. Taller height was associated with higher concentrations of IGF‐I and IGFBP‐3 and lower concentrations of IGFBP‐1. Smokers had higher concentrations of IGFBP‐1 and IGFBP‐2 and lower concentrations of IGFBP‐3 than nonsmokers. Higher alcohol consumption was associated with higher concentrations of IGF‐II and lower concentrations of IGF‐I and IGFBP‐2. African Americans had lower concentrations of IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 and Hispanics had lower IGF‐I, IGF‐II and IGFBP‐3 than non‐Hispanic whites. These findings indicate that a range of anthropometric, behavioural and sociodemographic factors are associated with circulating concentrations of IGFs and IGFBPs in men, which will lead to a greater understanding of the mechanisms through which these factors influence cancer risk.

The relationship between IGF-I and -II concentrations and body composition at birth and over the first 2 months.

Background:Insulin-like growth factors (IGF)-I and -II play an important role in prenatal growth. During the first two months from birth, body fat doubles, and rapid weight gain during this time increases future risk of cardiometabolic disease.Objective:To determine if IGF measurements at birth associate with body composition and the trajectory of its changes in the first two months.Methods:Umbilical cord IGF-I and -II concentrations were measured in term infants. Air displacement plethysmography was performed at birth and two months. Fat mass (FM) and fat free mass (FFM) were corrected for infant length (L) to FM/L3 and FFM/L2 respectively.Results:In 601 (317 male) infants, IGF-I concentrations at birth were associated with FM/L3 and FFM/L2 Z-scores at birth (R2=0.05 and 0.04 respectively, P<0.001), and IGF-II concentrations were associated with FFM/L2 Z-scores at birth (R2=0.01, P=0.02). Lower IGF-I concentrations were weakly associated with increases in FM/L3 Z-scores over the first two months (R2= 0.01, P=0.003).Conclusion:IGF-I concentrations at birth are associated with adiposity and lean mass at birth and inversely with the trajectory of FM accumulation over the first two months. IGF-I measurements only account for a small amount of the variance in these measures.

Metabolic Status of Dairy Cows Grouped by Anabolic and Catabolic Indicators of Metabolic Stress in Early Lactation

Background: Early lactation is period followed by changed metabolism in organism of the cow. This is the consequence of negativ energy balance, metabolic stress and milk production. Early lactation is characterised by high lipide catabolism (high NEFA) and low anabolic capacity (low insulin and IGF-I concentration). The aim of this study is to examine differences in metabolic adaptation of cows in early lactation (eight weeks after calving) in accordance to anabolic (insulin, IGF-I) and catabolic (NEFA) indicators in first week after calving.Materials, Methods &amp; Results: The experiment included 50 Holstein-Friesian cows. Blood samples were collected in first, second, fourth and eight week after calving by venepunction of v.coccigea. Based on median value of indicator, cows were significantly (P &lt; 0.001) classified in two groups: cows under metabolic stress (indicators of anabolism below the median Me-: indicators of catabolism above the medianMe+) and cows in control group (indicators of anabolism above the median Me+: indicators of catabolism under median Me-). Following criteria for comparison were given: based on classification of cows according to one indicator of metabolic load (insulinMe-:insulinMe+; IGF-IMe-:IGF-IMe+ and NEFAMe-:NEFA Me+); based on classification of cows according to combination of two indicators (insulinMe-+NEFAMe+: insulinMe++NEFAMe- and IGF-IMe-+NEFAMe+:IGF-IMe++NEFAMe-). Cows loaded with metabolic stress showed significan difference in metabolic adaptation in relation to control group (P &lt; 0.05 or P &lt; 0.01): higher values of STH, BHB (criteria were insulin, IGF-I, NEFA, insulin+NEFA, IGF-I+NEFA), higher values of bilirubin, AST, ALT, GGT, AP (criteria NEFA and IGF-I+NEFA) and MDA (criteria NEFA) and lower levels of glucose, total proteins, albumin (criteria IGF-I, NEFA, IGF-I+NEFA and body condition (criteria insulin, IGF-I, NEFA, insulin+ NEFA, IGF-I+ NEFA) were noted. Differences were expressed the most in first two weeks after calving. Differences in the body condition were the most notable later in weeks. Usage of NEFA indicator in first week after calving allows the most quality recognition of cows with metabolic parameters in extreme quartiles (ROC AUC= 0.87, P &lt; 0.01) in first eight week of lactation.Discussion: Inverse relation betwen NEFA with insulin and IGF-I is consequence of next phisiological concept: plasma insulin and IGF-I decrease in same mannure after calvig and insulin aplication increase IGF-I; low insulin concentration leads cow to lipolysis and low IGF-I leads to STH resistance with increase concentration of STH and high lipolysis. Catabolism of adipose tissue and high NEFA concentration is most important for metabolic adaptation in periparturient period. Cows with insulin resistance, ketosis and fatty liver with many problems in metabolic adaptation showed high NEFA concentration. Atenuation of NEFA by niacin or anti-inflammatory drug decreases metabolic change due to high lipide mobilisation in early lactation. Low antepartal IGF-I showed significant effect on postpartum health, but our measuremens are in first week postpartum. In addition, increase catabolism of lipide viewed in NEFA value contributes to metabolic variation and adaptation in the first eight weeks of lactation much more than decrease of anabolic indicators such as insulin and IGF-I. The combination of the indicators does not lead to better recognition of cows with extreme metabolic change in relation to classification only to the value of NEFA.

Correlation of Insulin-Like Growth Factor-I and -II Concentrations at Birth Measured by Mass Spectrometry and Growth from Birth to Two Months

Background: Immunoassays used to measure insulin-like growth factor (IGF)-I and -II concentrations are susceptible to interference from IGF-binding proteins. The aim of this study was to investigate the association of IGF-I and -II concentrations at birth with neonatal anthropometry using a liquid chromatography/mass spectrometry (LCMS) assay. Methods: LCMS was used to measure IGF-I and -II concentrations in umbilical cord blood of term, healthy infants enrolled in the Cork BASELINE Birth Cohort Study. Weight, length, and occipitofrontal head circumference (OFC) were measured at birth and 2 months. Results: Cord blood IGF-I and -II concentrations were measured in 1,100 infants. Mean (SD) IGF-I and -II concentrations were 52.5 (23.9) ng/mL and 424.3 (98.2) ng/mL, respectively. IGF-I and -II concentrations at birth were associated (p < 0.05) with weight (R² = 0.19, R² = 0.01), length (R² = 0.07, R² = 0.004), and OFC (R² = 0.03, R² = 0.04) at birth. Low IGF-I concentrations at birth were associated with increases in weight (p < 0.001) and OFC (p < 0.01) Z-scores in the first 2 months. Conclusion: Using an LCMS assay, we have shown that anthropometric parameters at birth are associated with IGF-I and weakly with IGF-II concentrations. This indicates that, at the time of birth, IGF-I is the more important growth factor for regulating infant growth.

Effects of reducing dietary starch content by replacing barley grain with wheat dried distillers grains plus solubles in dairy cow rations on ovarian function

Our objective was to evaluate the effects of dietary starch content, altered by partial substitution of dietary grain with wheat dried distillers grain with solubles (DDGS), on the interval from calving to first ovulation, concentrations of hormones and metabolites in plasma and follicular fluid, and granulosa cell gene expression in preovulatory follicles. Sixty lactating dairy cows were assigned to 1 of 2 diets from calving until 84d postpartum. Diets were formulated to contain either 17.3% rolled barley grain (29.2% starch) or 17.2% wheat DDGS (19.1% starch), with 43.0% barley silage and 21.6% rolled corn grain as the other major ingredients (dry matter basis). Transrectal ultrasonography was performed twice weekly to monitor ovarian dynamics from 7±2d postpartum until ovulation or until 56d in milk, whichever occurred earlier. Plasma concentrations of insulin and insulin-like growth factor-1 (IGF-1) were determined in all 60 cows, and that of glucose, fatty acids, and urea in a subset of 24 cows, representing those in which the first ovulation occurred spontaneously within 5 wk postpartum. Estradiol (proestrus) and progesterone (12d postovulation) in plasma were also measured. Concentrations of insulin, IGF-1, glucose, fatty acids, and urea were determined in follicular fluid (wk 9), and the expression of LH receptor, estrogen receptor β, cytochrome P450 aromatase, and plasma type glutathione peroxidase genes measured in granulosa cells obtained from the preovulatory follicles at wk 9 postpartum in the subset of 24 cows. Diets did not alter the interval from calving to first ovulation (32.3±2.5d), but a significantly lower proportion of cows on the DDGS diet (20%) ovulated multiple (≥2) follicles at the first ovulation than those on the barley grain diet (40%). The incidence of multiple ovulations tended to be lower at first insemination (10 vs. 21% for cows fed DDGS and barley grain diets, respectively). Mean plasma concentration of insulin was higher in cows fed the barley grain diet (2.5 vs 1.6 IU/mL), and a diet by time interaction was noted, with cows on the barley grain ration having higher insulin from wk 6 to 12 postpartum; however, mean plasma IGF-1 concentration did not differ between dietary groups. In the subsets, mean plasma concentrations of metabolites or estradiol and progesterone were not affected by diet, parity, or diet by parity interactions. Cows on the DDGS diet had lower concentrations of IGF-I (69 vs. 108 ng/mL) and higher fatty acids (222 vs. 149mEq/L) in the follicular fluid obtained from preovulatory follicles. Diet, parity, and diet by parity interactions did not affect the concentrations of insulin, glucose, urea, estradiol, and progesterone in follicular fluid. Diets did not alter the expression profiles of LHr, estrogen receptor β, CYP19, and GPx3 genes in granulosa cells. In summary, diets did not affect the interval from calving to first ovulation or granulosa cell gene expression. However, reducing dietary starch content by a partial replacement of dietary grain with wheat DDGS increased fatty acids in follicular fluid and reduced the concentrations of insulin in plasma, IGF-1 in follicular fluid, and the incidence of multiple ovulations.

Relationship between Foetal Growth Restriction and Maternal Nutrition Status Measured by Dual-Energy X-Ray Absorptiometry, Leptin, and Insulin-Like Growth Factor

Aims: The aim of this study was to determine if maternal nutritional status, as defined by body composition, leptin, and insulin-like growth factor (IGF)-I levels, relates to foetal growth. Methods: In this prospective study, mothers of foetuses with foetal growth restriction (FGR; cases; n = 46) and mothers of appropriate-for-gestational-age (AGA) foetuses (controls; n = 81) were consecutively recruited over a 14- month period. A maternal blood sample was obtained during the third trimester (between 32 and 34 weeks of gestation) for the assessment of IGF-I and leptin. Body composition was assessed by dual-energy X-ray absorptiometry within the first 15 days after delivery. The study used the SPSS-PC statistical package, version 19.0, and p < 0.05 was considered statistically significant. Results: Mean serum IGF-I levels were lower in the cases than in the controls (p < 0.05), whereas leptin concentrations were higher in the cases after adjusting for age, body mass index and cigarette consumption (p < 0.05). Cases had less lean and fat tissue than controls (p < 0.05) but a relatively higher fat percentage. Conclusions: The mothers of foetuses with FGR have a body composition pattern characterized by a slightly increased fraction of fat mass, lower IGF-I concentrations, and increased serum leptin levels. Optimization of maternal nutritional status should be considered, as the nutritional status may be involved in the pathogenesis of FGR.

Low-Oxygen Tension and IGF-I Promote Proliferation and Multipotency of Placental Mesenchymal Stem Cells (PMSCs) from Different Gestations via Distinct Signaling Pathways

The microenvironment of placental mesenchymal stem cells (PMSCs) is dynamic throughout gestation and determines changes in cell fate. In vivo, PMSCs initially develop in low-oxygen tension and low IGF-I concentrations, and both increase gradually with gestation. The impact of varying concentrations of IGF-I and changing oxygen tension on PMSC signaling and multipotency was investigated in PMSCs from early (preterm) and late (term) gestation human placentae. Preterm PMSCs had greater proliferative response to IGF-I, which was further enhanced by low-oxygen tension. Low-oxygen tension alone was sufficient to induce ERK1/2 phosphorylation, whereas IGF-I was required for AKT (protein kinase B) phosphorylation. Low-oxygen tension prolonged ERK1/2 and AKT phosphorylation with a slowed phosphorylation decay even in presence of IGF-I. Low-oxygen tension maintained higher levels of IGF-I receptor and insulin receptor substrate 1 that were otherwise decreased by exposure to IGF-I and induced a differential phosphorylation pattern on IGF-I receptorβ and insulin receptor substrate 1. Phosphorylation of ERK1/2 and AKT was different between the preterm and term PMSCs, and phospho-AKT, and not phospho-ERK1/2, was the major determinant of PMSC proliferation and octamer-4 levels. These studies demonstrate that low-oxygen tension regulates the fate of PMSCs from early and late gestations in response to IGF-I, both independently and dependently, via specific signal transduction mechanisms.

Low postnatal serum IGF‐I levels are associated with bronchopulmonary dysplasia (BPD)

Aim:To characterize postnatal changes in serum insulin-like growth factor-1 (IGF-I) in relation to development of bronchopulmonary dysplasia (BPD) in very preterm infants.Methods:Longitudinal study of 108 infants with mean (SD) gestational age (GA) 27.2 (2.2) weeks. Weekly serum samples of IGF-I were analysed from birth until postmenstrual age (PMA) 36 weeks. Multivariate models were developed to identify independent predictors of BPD.Results:Postnatal mean IGF-I levels at postnatal day (PND) 3–21 were lower in infants with BPD compared with infants with no BPD (16 vs. 26 μg/L, p < 0.001). Longitudinal postnatal change in IGF-I levels (IGF-I regression coefficient (β)), PNDs 3–21, was lower in infants with BPD compared with infants with no BPD (0.28 vs. 0.97, p = 0.002) and mean IGF-I during PMA 30–33 weeks was lower in infants with BPD as compared with infants without BPD (22 vs. 29 μg/L, p < 0.001). In a binomial multiple regression model, lower GA, male gender and lower mean serum IGF-I levels during PND 3–21 were the most predictive risk factors associated with BPD (r2 = 0.634, p < 0.001).Conclusion:Lower IGF-I concentrations during the first weeks after very preterm birth are associated with later development of BPD.

Novel missense mutation in the IGF‐I receptor L2 domain results in intrauterine and postnatal growth retardation

IGFs play key roles in intrauterine and postnatal growth through the IGF-I receptor (IGF-IR). We identified a family bearing a new heterozygous missense mutation at the L2 domain of IGF-IR (R431L). We analysed the nucleotide sequences of the IGF1R gene of the family. We prepared R(-) cells (fibroblasts with targeted disruption of the IGF-IR gene) expressing wild-type or R431L IGF-IR and performed functional analyses by evaluating IGF-I binding, IGF-I-stimulated DNA synthesis, tyrosine phosphorylation of IGF-IR and its substrates, and internalization by measuring [(125) I]IGF-I internalization. We also performed confocal microscopy analysis. We identified a family bearing a new heterozygous missense mutation at the L2 domain of IGF-IR (R431L) through an 8-year-old girl and her mother, both born with intrauterine growth retardation. In experiments conducted using cells homozygously transfected with the IGF-IR R431L mutation; (i) IGF-I binding was not affected; (ii) DNA synthesis induced by IGF-I was decreased; (iii) IGF-IR internalization stimulated by IGF-I was decreased and (iv) IGF-I-stimulated tyrosine phosphorylation was reduced IGF-IR by low concentrations of IGF-I and on insulin receptor substrate (IRS)-1 and IRS-2. A missense mutation (R431L) leads to the inhibition of cell proliferation, attenuation of IGF signalling and decrease in internalization of IGF-IR. The results of this study suggest a novel link between a mutation at the IGF-IR L2 domain and intrauterine and postnatal growth retardation.

Meta-Analysis and Dose-Response Metaregression: Circulating Insulin-Like Growth Factor I (IGF-I) and Mortality

IGF-I plays a central role in metabolism and growth regulation. High IGF-I levels are associated with increased cancer risk and low IGF-I levels with increased risk for cardiovascular disease. Our objective was to determine the relationship between circulating IGF-I levels and mortality in the general population using random-effects meta-analysis and dose-response metaregression. We searched PubMed, EMBASE, Web of Science, and Cochrane Library from 1985 to September 2010 to identify relevant studies. Population-based cohort studies and (nested) case-control studies reporting on the relation between circulating IGF-I and mortality were assessed for eligibility. Data extraction was performed by two investigators independently, using a standardized data extraction sheet. Twelve studies, with 14,906 participants, were included. Overall, risk of bias was limited. Mortality in subjects with low or high IGF-I levels was compared with mid-centile reference categories. All-cause mortality was increased in subjects with low as well as high IGF-I, with a hazard ratio (HR) of 1.27 (95% CI = 1.08-1.49) and HR of 1.18 (95% CI = 1.04-1.34), respectively. Dose-response metaregression showed a U-shaped relation of IGF-I and all-cause mortality (P = 0.003). The predicted HR for the increase in mortality comparing the 10th IGF-I with the 50th percentile was 1.56 (95% CI = 1.31-1.86); the predicted HR comparing the 90th with the 50th percentile was 1.29 (95% CI = 1.06-1.58). A U-shaped relationship was present for both cancer mortality and cardiovascular mortality. Both low and high IGF-I concentrations are associated with increased mortality in the general population.

Atypical GH Insensitivity Syndrome and Severe Insulin-Like Growth Factor-I Deficiency Resulting from Compound Heterozygous Mutations of the GH Receptor, Including a Novel Frameshift Mutation Affecting the Intracellular Domain

Background/Aims: GH insensitivity and IGF deficiency may result from aberrations of the GH receptor (GHR). We describe a 4-year-old child with modest growth failure and normal serum concentrations of GH-binding protein (GHBP), but clinical evidence of GH insensitivity. Method: Serum and DNA samples from the proband and his parents were analyzed. Results: The child had a height of –4 SD, elevated serum GH concentrations, abnormally low serum IGF-I and IGFBP-3 concentrations and normal GHBP concentrations. DNA analysis revealed compound heterozygosity for mutations of GHR, including a previously reported R211H mutation and a novel duplication of a nucleotide in exon 9 (899dupC), the latter resulting in a frameshift and a premature stop codon. Treatment with recombinant DNA-derived IGF-I resulted in growth acceleration. Conclusion: Mutations affecting the intracellular domain of the GHR can result in GH insensitivity and IGF deficiency, despite normal serum concentrations of GHBP. The presence of clinical and biochemical evidence of GH resistance is sufficient to consider the possibility of aberrations of the GHR, even in the presence of normal serum GHBP concentrations.

Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action

ABSTRACT Context and Objective Main features of the autosomal dominant form of GH deficiency (IGHD II) include markedly reduced secretion of GH combined with low concentrations of IGF-I leading to short stature. Design, Setting, and Patients A female patient presented with short stature (height −6.0 sd score) and a delayed bone age of 2 yr at the chronological age of 5 yr. Later, at the age of 9 yr, GHD was confirmed by standard GH provocation test, which revealed subnormal concentrations of GH and a very low IGF-I. Genetic analysis of the GH-1 gene revealed the presence of a heterozygous R178H mutation. Interventions and Results AtT-20 cells coexpressing both wt-GH and GH-R178H showed a reduced GH secretion after forskolin stimulation compared with the cells expressing only wt-GH, supporting the diagnosis of IGHD II. Because reduced GH concentrations found in the circulation of our untreated patient could not totally explain her severe short stature, functional characterization of the GH-R178H performed by studies of GH receptor binding and activation of the Janus kinase-2/signal transducer and activator of transcription-5 pathway revealed a reduced binding affinity of GH-R178H for GH receptor and signaling compared with the wt-GH. Conclusion This is the first report of a patient suffering from short stature caused by a GH-1 gene alteration affecting not only GH secretion (IGHD II) but also GH binding and signaling, highlighting the necessity of functional analysis of any GH variant, even in the alleged situation of IGHD II.

Growth Hormone (GH) Deficiency Type II: A Novel GH-1 Gene Mutation (GH-R178H) Affecting Secretion and Action

Main features of the autosomal dominant form of GH deficiency (IGHD II) include markedly reduced secretion of GH combined with low concentrations of IGF-I leading to short stature. A female patient presented with short stature (height -6.0 sd score) and a delayed bone age of 2 yr at the chronological age of 5 yr. Later, at the age of 9 yr, GHD was confirmed by standard GH provocation test, which revealed subnormal concentrations of GH and a very low IGF-I. Genetic analysis of the GH-1 gene revealed the presence of a heterozygous R178H mutation. AtT-20 cells coexpressing both wt-GH and GH-R178H showed a reduced GH secretion after forskolin stimulation compared with the cells expressing only wt-GH, supporting the diagnosis of IGHD II. Because reduced GH concentrations found in the circulation of our untreated patient could not totally explain her severe short stature, functional characterization of the GH-R178H performed by studies of GH receptor binding and activation of the Janus kinase-2/signal transducer and activator of transcription-5 pathway revealed a reduced binding affinity of GH-R178H for GH receptor and signaling compared with the wt-GH. This is the first report of a patient suffering from short stature caused by a GH-1 gene alteration affecting not only GH secretion (IGHD II) but also GH binding and signaling, highlighting the necessity of functional analysis of any GH variant, even in the alleged situation of IGHD II.

Rams genetically superior for IGF-I do not exhibit improved male reproductive traits

Insulin-like growth factors (IGFs) play an important role in regulating normal physiology, and may be involved in the control of reproduction. The aim of this study was to define the relationship between IGF-I concentrations and reproductive performance over the breeding and non-breeding seasons in lines of New Zealand Romney rams that had been selected for low and high blood serum IGF-I concentration. Yearling rams from two selection lines (13 from the high line and 19 from the low line) were examined in July (winter), September (autumn) and November (summer) 2006 and March (spring) 2007. Scrotal circumference including the inguinal skin was recorded. Semen was collected by electroejaculation on 4 occasions over a 12-month period. Semen was evaluated according to standard procedures (volume, motility, density and morphology). Samples were collected from four animals from each group for measurements of mRNA for IGF-I and the IGF type 1 receptor (IGF 1R) in the testis, and IGF-I, IGF 1R and the insulin receptor (IR) in the liver. Blood samples were collected via jugular venipuncture for the measurement of IGF-I, insulin and testosterone. The incidences of morphologically abnormal sperm cells, the scrotal circumference and sperm motility were higher in the breeding than in non-breeding season. Seasonal changes were found in the percentage of abnormal sperm, scrotal circumference, sperm motility and sperm density, but there were no differences between lines in any reproductive parameters. IGF-I mRNA levels were higher in the high than the low line in the liver but not in the testis, whereas the opposite was found for levels of IGF 1R mRNA. mRNA levels for the insulin receptor in the liver were higher in the high line. Plasma testosterone concentrations did not differ between lines, whereas the concentrations of IGF-I and insulin were higher in the high line. The results suggest that IGF-I may be locally produced in the liver and the testis, and that selection for high IGF-I may not be associated with improved reproductive performance in rams.

Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age.

IGF-I is considered to be one of the most important growth factors during puberty. Information concerning its correlation to thyroid hormones (T3, T4), adrenal and sex steroids is limited to puberty and the elderly. The presented study included 455 subjects (among them 259 children) ranging in age from newborn to 100 years. Serum IGF-I concentrations increase from childhood to the end of puberty (2 years earlier in girls). There are close positive correlations between IGF-I concentrations and age, height and weight and between IGF-I and estradiol or testosterone concentration in girls and boys respectively, and the DHEA-S level in boys during puberty. Correlations also exist with T3, aldosterone and 17 OH-progesterone in boys and girls in the pubertal stages I-V and with T4 in stages I-IV. Compared to 20-30 year-old subjects IGF-I concentrations amounted to 59% after 60 years, 43% in men and 54% in women after 70 years and 29% after 90 years. It is suggested that increasing adrenal DHEA-S concentrations stimulate IGF-I synthesis and by means of gonadal steroidogenesis, increase the pubertal GH secretion and the further pubertal IGF-I increase. The low IGF-I concentrations in patients > 60 years reflect the more catabolic metabolism of the elderly.

Somatotropic axis components and nutrient partitioning in genetically diverse dairy cows managed under different feed allowances in a pasture system

The somatotropic axis [including growth hormone (GH), GH receptor, and insulin-like growth factor (IGF)-I] is uncoupled in high-producing cows in early lactation so that the liver fails to respond to GH and produces less IGF-I. This uncoupling was implicated in the process of nutrient partitioning, enabling high milk production. Different genetic selection goals may affect functional components of the somatotropic axis. Thus, the somatotropic axis was examined in diverse genetic strains of dairy cows [North American Holstein 1990 (NA90), New Zealand Holstein-Friesian 1990 (NZ90), and New Zealand Holstein-Friesian 1970 (NZ70)] that were managed similarly within a pasture-based system but were offered feed allowances commensurate with their genetic ability to produce milk. The NA90 cows produced more milk (26.2±0.3, 24.1±0.3, and 20.1±0.4kg/d, for NA90, NZ90, and NZ70, respectively), but had lower milk fat percentages (4.28±0.03, 4.69±0.03, and 4.58±0.04kg/d for NA90, NZ90, and NZ70, respectively) compared with both NZ strains. Milk protein percentages (3.38±0.02, 3.52±0.02, and 3.29±0.03kg/d for NA90, NZ90, and NZ70, respectively) were greater for NZ90 cows. During early lactation (wk 2 to 6), the total net energy produced in milk was greater in NA90 compared with NZ90 or NZ70 cows, but total net energy in milk after wk 6 was equivalent for NA90 and NZ90 cows. The greater milk production in early lactation in NA90 cows was associated with lower body condition scores (BCS; 1 to 10 scale; 4.0±0.1) elevated blood GH concentrations (1.6±0.1ng/mL), and low blood IGF-I concentrations (14.8±1.1ng/mL), indicating an uncoupled somatotropic axis. In comparison, the NZ70 cows retained a coupled somatotropic axis during early lactation, maintaining greater BCS (4.6±0.1), lower blood GH (0.7±0.1ng/mL), and greater blood IGF-I (21.9±1.2ng/mL). The degree of uncoupling in NZ90 cows was intermediate between the other 2 strains. Additional feed allowance failed to change blood IGF-I concentrations in NA90 cows but increased IGF-I concentrations in NZ90 cows (20.9±1.4 and 13.2±1.4ng/mL for the high and low feed allowance, respectively). Furthermore, additional feed allowance in NZ90 cows lessened BCS loss in early lactation, but did not affect BCS loss in NA90 cows. Functional components of the somatotropic axis differed for the respective strains and were consistent with strain differences in milk production, BCS, and feed allowance.

Growth Hormone (GH) or Insulin-like Growth Factor (IGF)-I Represses 11.BETA.-Hydroxysteroid Dehydrogenase Type 1 (HSD1) mRNA Expression in 3T3-L1 Cells and Its Activity in Their Homogenates

Patients with growth hormone (GH) deficiency (GHD) have a clinical feature of visceral adiposity and it has been reported that these patients have an increased active cortisol (F)/inactive cortisone (E) metabolite ratio. 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is an enzyme expressed in liver and adipose tissue that acts principally as a reductase converting E to F. In the present study, we investigated the effects of GH or IGF-I on the activity of 11beta- HSD1 in 3T3-L1 cell homogenates and its mRNA expression. First, we showed that 11beta-HSD1 activity and mRNA levels were low in preadipocytes and increased throughout the process of adipogenesis. When fully differentiated adipocytes were treated with GH for various times, the activity of 11beta-HSD1 was significantly decreased after 4 h and 8 h but was restored to basal levels after 24 h. After 8 h of GH stimulation, 11beta-HSD1 mRNA levels were decreased compared with basal levels. IGF-I treatment of adipocytes resulted in rapid decreases in 11beta-HSD1 activity as well as mRNA levels; however, IGF-I treatment for 24 h increased 11beta-HSD1 activity. In long-term cultured adipocytes, GH or IGF-I showed only inhibitory effects on 11beta-HSD1 activity. In conclusion, 11beta-HSD1 activity was suppressed by GH or IGF-I in differentiated adipocytes, probably due to a reduction of 11beta-HSD1 mRNA levels. These data suggest that under the conditions of low GH or IGF-I concentrations, 11beta-HSD1 activity in adipose tissue is maintained at high levels, leading to an increase in active cortisol that induces adipogenesis and/or lipogenesis. Thus, visceral adiposity in patients with GHD might be related to increased 11beta-HSD1 activity.